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Introduction
Gastrointestinal flora influence health,1 but the composition 
of flora can be adapted by consuming prebiotics or 
probiotics.2 Prebiotics are nondigestible substances that 
stimulate the growth of health-promoting bacteria in the 
colon, such as bifidobacteria.3-5 They are live microbial 
feed supplements which improve the intestinal microbial 
balance.4 
Immediately after birth, bacterial colonisation of the infant’s 
gut begins with bifidobacteria and lactobacilli.6 These 
organisms are transferred from the maternal microbial flora 
in the genital tract and colon during delivery, and also from 
the environment.4 
Gut-associated immune tissue comprise 80% of the 
immune system, making the composition of intestinal 
flora an important factor in the immune system.7 It is 
believed that the onset of many diseases possibly relates 
to disruption of the early colonisation of the gut.5 Preterm 
infants have delayed colonisation of the gut with beneficial 
flora by three to four weeks, but colonisation with pathogens 
occurs earlier and contributes to health problems, such as 
necrotising enterocolitis (NEC).8
 Breastfed infants are often healthier than formula-fed infants 
and can fight infections better.9 Breast milk naturally contains 
prebiotics (oligosaccharides) at a level of 10-12 g/l. These 
oligosaccharides favour the growth of bifidobacteria in the 
colon. Exclusively breastfed infants have higher numbers 
of bifidobacteria and lower numbers of the Escherichia coli 
bacteria, while formula-fed infants harbour equal amounts 
of these different types of intestinal flora.3,6,10,11 
There are various reasons for this, including the lower 
content and different composition of proteins in breast 
milk, the lower phosphorous content, and oligosaccharides 
and mediators of immune function that are found in human 
milk. Infant formula lacks these benefits.1 Breastfeeding 
protects against allergies and infections. This is thought 
to be partly due to the presence of more bifidobacteria in 
the gut. Therefore, breast milk stimulates the development 
of the infant’s immune system.2 Bifidus-dominated flora is 
protective as it activates the immune system and inhibits 
invading pathogens that can cause infections. There is 
also some evidence that infants who suffer from allergies 
have less bifidobacteria and lactobacilli in their colons.2 
Often, infant formula is supplemented with probiotics and 
prebiotics to help promote the development of a bifidus-
dominated flora, with the goal of creating an intestinal flora 
composition that is similar to that of a breastfed infant.3
Probiotic-supplemented formula
The overall health benefit and efficacy of adding probiotics 
to infant formula remains to be demonstrated in large 
randomised clinical trials (RCTs). A clinical report by the 
American Academy of Paediatrics reviewed the currently 
known health benefits of probiotic and prebiotic products, 
including those that are added to commercially available 
infant formula and other food products for children.5
The report states that the use of probiotics has been 
shown to be modestly effective in RCTs in treating acute 
viral gastroenteritis in healthy children, and preventing 
antibiotic-associated diarrhoea in healthy children. There 
is some evidence that probiotics prevent NEC in very low 
birthweight infants (birthweight between 1 000-1 500 g), but 
more studies are needed.
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The committee on nutrition of the European Society for 
Paediatric Gastroenterology, Hepatology and Nutrition 
(ESPGHAN) systematically reviewed published evidence 
relating to the safety and health effects of the administration 
of formula that was supplemented with probiotics and/or 
prebiotics, and compared it to that on unsupplemented 
formula.12
The committee concluded that there currently are no safety 
concerns regarding feeding probiotic- and/or prebiotic-
supplemented formula to healthy infants, but there are 
insufficient data to recommend the routine use of probiotic- 
and/or prebiotic-supplemented formula. They acknowledge 
the importance of more research in this field. 
An effective probiotic must be nonpathogenic and nontoxic 
and exert a beneficial effect on the host. Moreover, it 
should be capable of surviving passage through the 
gastrointestinal tract, particularly the harsh environmental 
conditions in the human stomach and small intestine. 
Probiotic supplementation in infant formula has shown that 
some strains may persist in the infant gut and lower stool 
pH.4
Probiotics in the treatment or prevention 
of selected clinical diseases
Infectious diarrhoea
Results of published RCTs have indicated that there is 
modest benefit when giving probiotics to prevent acute 
gastrointestinal tract infections in healthy infants and 
children. The strains of probiotics that were used included 
Lactobacillus rhamnosus GG (LGG), Streptococcus 
thermophilus, L. casei, Bifidobacterium lactis, or L. reuteri 
mixed with milk or infant formula or given as an oral 
supplement. Rotavirus was the most common cause of 
acute diarrhoea in the RCTs.5
Results of meta-analyses13 -15 and a Cochrane review16 have 
been published on the benefit of probiotics in treating acute 
infectious diarrhoea in children. These reports indicate that 
probiotics reduce the number of diarrheal stools and the 
duration (approximately by one day) of the diarrhoea.
Antibiotic-associated diarrhoea
Reviews showed that use of a probiotic-supplemented 
formula reduces the incidence of antibiotic-associated 
diarrhoea. B. lactis and S. thermophilus had the greatest 
effect.5,7 A meta-analysis17 of published results from RCTs 
on probiotic use in the prevention of antibiotic-associated 
diarrhoea in children indicated a beneficial effect. Children 
received either a probiotic-supplemented formula or a 
separate probiotic as preventive treatment. No RCTs 
have been published that have investigated the effect of 
probiotics when treating antibiotic-associated diarrhoea in 
children. Thus, their use cannot be recommended.5
Infantile colic
Formula with B. lactis BL999 and LPR, L. reuteri or LGG is also 
not associated with a decreased frequency of colic, crying 
and irritability in children younger than six months,12 but the 
use of B. lactis and S thermophilus is associated with a lesser 
frequency of colic in children older than six months. No effect 
was observed with the use of B lactis alone, L. reuteri or 
L. salivarius.12
It is speculated that probiotics may change patterns 
of fermentation in the colon, leading to less gas or 
water fermentation, which may improve gastrointestinal 
tolerance.10 Further confirmatory RCTs are required to 
recommend the routine use of probiotics in the treatment 
of infantile colic in both breastfed and formula-fed infants.5
Respiratory infections
Limited evidence shows that formula that is supplemented 
with B. lactis does not decrease the risk of respiratory 
infections, and B. longhum BL999 and L. rhamnosus LPR are 
not associated with a decreased use of antibiotics in infants 
younger than six months.12 There is also limited evidence to 
show that a combination of B. lactis and S. thermophilus or 
L. reuteri is associated with a decreased use of antibiotics 
in children older than six months.12
Allergies
Insufficient evidence was found to recommend the use 
of probiotics in infant feeds to prevent food allergies or 
sensitivities.5,18 The ESPGHAN concluded that limited 
available data suggest that the probiotics studied 
(B. longhum BL999 and LPR) had no effect on allergies. 
However, the committee considered that there is too much 
uncertainty to draw reliable conclusions from the available 
data.12
Prebiotic-supplemented formula
Examples of prebiotic oligosaccharides include fructooligo-
saccharides (FOS), inulin, galacto-oligosaccharides (GOS), 
and soybean oligosaccharides.5 Supplemented bifidobacte-
rial species colonise the intestine of infants who receive the 
supplementation.10 The use of oligosaccharides in formula 
results in higher bifidobacteria counts in stools. Faecal lac-
tobacilli can also increase, but the clinical benefits are not 
clear.6,12 Prebiotic-supplemented formula has a limited ef-
fect on the reduction of pathogenic bacteria. The response 
to prebiotics in formula is thought to be dependent on the 
healthy gut flora prior to supplementation. Some stud-
ies show a dose-dependent effect of the prebiotics on the 
stimulating effect of bifidobacteria and lactobacilli growth.6 
Supplementation of formula with a mixture of FOS/GOS has 
no negative effects. There is a modest improved effect on 
growth in children younger than six months.12 However, it 
is associated with a slightly higher weight gain in children 
older than six months.6
The use of prebiotics in formula can potentially reduce the 
stool pH of children younger than six months.6,12 Limited 
evidence shows that such formula potentially leads to 
increased stool frequency and softer stools, similar to that 
of breastfed infants.6,12 
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Furthermore, infants who receive GOS/FOS might have 
fewer episodes of infections and require fewer antibiotics. 
The total number of infections, cumulative incidence of 
infections and the number of recurring infections during 
the first six months might be reduced.11 However, evidence 
regarding the use of prebiotics in the prevention of allergies 
is inconclusive.19 
Prebiotic-supplemented infant formula is mostly well 
tolerated. To date, these products seem to be safe in healthy 
infants. FOS and GOS may be voluntarily added to infant 
formula (< 0.8 g/100 ml) in a ratio of 90% GOS:10% FOS. 
The Food and Agricultural Organization (FAO) of the United 
Nations supports the supplementation of formula with 
prebiotics in infants aged five months and older, as these 
infants will have a mature immune system and intestinal 
colonisation.
Prebiotic- and probiotic-supplemented 
formula in preterm neonates
There is limited evidence that the supplementation of 
preterm formula with FOS/GOS is well tolerated, increases 
the bifidobacteria stool colony counts, decreases the 
growth of pathogenic bacteria, improves gastrointestinal 
transit time, and softens and acidifies stools to a degree 
that is similar to that in breastfed infants. Therefore, 
supplementation with prebiotics is safe, but routine use 
is not recommended.8 Premature infants have inadequate 
colonisation of the gut for various reasons. It is suspected 
that the establishment and composition of intestinal flora 
in preterm infants plays a role in the development of NEC. 
Theoretically, administration of probiotics to preterm infants 
should reduce gut pathogens, improve the structure and 
function of the gut, reduce the need for parenteral nutrition, 
facilitate enteral nutrition, improve the gut mucosal barrier 
function, decrease sepsis and antibiotic use, and prevent 
NEC.7
Conclusion and recommendations
The prebiotics and probiotics that are now being added to 
commercial infant formula are classified as GRAS (generally 
regarded as safe) by the FDA. 
The addition of probiotics to powdered infant formula 
has not been demonstrated to be harmful to healthy term 
infants. However, evidence of clinical efficacy regarding 
their addition is insufficient to recommend the routine use 
of such formula.5,12
The ESPGHAN committee on nutrition has concluded that at 
present, there are insufficient data to recommend the routine 
use of probiotic- and/or prebiotic-supplemented formula. 
Yet the administration of probiotic (single or in combination) 
supplementation to infant or follow-on formula, and given 
beyond early infancy, may be associated with some clinical 
benefits. These include a reduction in the risk of nonspecific 
gastrointestinal infections, a reduced risk of antibiotic use 
and a lower frequency of colic or irritability. Reviewed 
studies have varied with regard to methodological quality, 
the specific strains studied, the duration of the interventions 
and the doses used.
The FAO supports the use of prebiotics in infant formula 
for infants aged five months and older, as they have a more 
mature immune system. Products containing prebiotics or 
probiotics are not recommended for immunocompromised 
infants, ill preterm neonates and children with indwelling 
medical devices.5
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